3M CO (MMM) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $3.11B; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $6.10B; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $3.11B | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $3.11B |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $6.10B | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $6.10B |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 31.92B USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities · Commercial Paper |
| Amounts owed to suppliers | 3.11B USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Noncurrent · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | 6.10B USD | Other Liabilities, Current |
| Reported other noncurrent obligations | 8.13B USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $6.10B
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $609.00M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.11B | (m) | $6.10B | (m) | $31.92B | (m) | (m) | (m) | $8.13B | (m) |
| 2026-03-31 | (m) | $2.79B | (m) | $4.12B | (m) | $32.13B | (m) | (m) | (m) | $10.60B | (m) |
| 2025-12-31 | (m) | $2.70B | (m) | $4.45B | (m) | $32.99B | (m) | (m) | (m) | $10.83B | (m) |
| 2025-09-30 | (m) | $2.73B | (m) | $4.03B | (m) | $32.94B | (m) | (m) | (m) | $10.32B | (m) |
| 2025-06-30 | (m) | $2.84B | (m) | $3.21B | (m) | $33.64B | (m) | (m) | (m) | $11.14B | (m) |
| 2025-03-31 | (m) | $2.76B | (m) | $4.54B | (m) | $35.43B | (m) | (m) | (m) | $11.45B | (m) |
| 2024-12-31 | (m) | $2.66B | (m) | $5.47B | (m) | $35.97B | (m) | $15.00M | (m) | $11.38B | (m) |
| 2024-09-30 | (m) | $2.69B | (m) | $5.49B | (m) | $36.18B | (m) | (m) | (m) | $11.31B | (m) |
| 2024-06-30 | (m) | $2.81B | (m) | $9.05B | (m) | $39.39B | (m) | (m) | (m) | $11.10B | (m) |
| 2024-03-31 | (m) | $3.37B | (m) | $7.75B | (m) | $50.31B | (m) | $565.00M | (m) | $13.72B | (m) |
| 2023-12-31 | (m) | $3.25B | (m) | $7.61B | (m) | $45.71B | (m) | $572.00M | (m) | $14.32B | (m) |
| 2023-09-30 | (m) | $3.10B | (m) | $7.87B | (m) | $44.89B | (m) | $501.00M | (m) | $14.15B | (m) |
| 2023-06-30 | (m) | $3.23B | (m) | $3.47B | (m) | $41.02B | (m) | $521.00M | (m) | $14.65B | (m) |
| 2023-03-31 | (m) | $3.13B | (m) | $3.28B | (m) | $31.54B | (m) | $520.00M | (m) | $5.45B | (m) |
| 2022-12-31 | (m) | $3.18B | (m) | $3.19B | (m) | $31.68B | (m) | $538.00M | (m) | $5.62B | (m) |
| 2022-09-30 | (m) | $3.06B | (m) | $3.40B | (m) | $32.02B | (m) | $506.00M | (m) | $5.56B | (m) |
| 2022-06-30 | (m) | $3.27B | (m) | $3.18B | (m) | $31.82B | (m) | $503.00M | (m) | $4.68B | (m) |
| 2022-03-31 | (m) | $3.16B | (m) | $2.94B | (m) | $30.85B | (m) | $549.00M | (m) | $3.50B | (m) |
| 2021-12-31 | (m) | $2.99B | (m) | $3.19B | (m) | $31.95B | (m) | $529.00M | (m) | $3.40B | (m) |
| 2021-09-30 | (m) | $2.86B | (m) | $3.24B | (m) | $33.75B | (m) | $467.00M | (m) | $3.35B | (m) |
| 2021-06-30 | (m) | $2.93B | (m) | $3.18B | (m) | $33.79B | (m) | $475.00M | (m) | $3.30B | (m) |
| 2021-03-31 | (m) | $2.67B | (m) | $3.13B | (m) | $33.35B | (m) | $482.00M | (m) | $3.33B | (m) |
| 2020-12-31 | (m) | $2.56B | (m) | $3.28B | (m) | $34.41B | (m) | $498.00M | (m) | $3.46B | (m) |
| 2020-09-30 | (m) | $2.21B | (m) | $2.84B | (m) | $33.45B | (m) | $390.00M | (m) | $3.32B | (m) |
| 2020-06-30 | (m) | $1.98B | (m) | $2.70B | (m) | $34.16B | (m) | $412.00M | (m) | $3.27B | (m) |
| 2020-03-31 | (m) | $2.21B | (m) | $2.78B | (m) | $36.00B | (m) | $422.00M | (m) | $3.23B | (m) |
| 2019-12-31 | (m) | $2.23B | (m) | $3.06B | (m) | $34.53B | (m) | $430.00M | (m) | $3.27B | (m) |
| 2019-09-30 | (m) | $2.08B | (m) | $2.73B | (m) | $31.79B | (m) | $605.00M | (m) | $3.23B | (m) |
| 2019-06-30 | (m) | $2.13B | (m) | $3.17B | (m) | $28.83B | (m) | $603.00M | (m) | $3.27B | (m) |
| 2019-03-31 | (m) | $2.31B | (m) | $3.07B | (m) | $29.38B | (m) | $619.00M | (m) | $3.23B | (m) |
| 2018-12-31 | (m) | $2.27B | (m) | $2.77B | (m) | $26.65B | (m) | $617.00M | (m) | $3.01B | (m) |
| 2018-09-30 | (m) | $2.03B | (m) | $3.03B | (m) | $26.96B | (m) | $614.00M | (m) | $2.91B | (m) |
| 2018-06-30 | (m) | $1.87B | (m) | $2.87B | (m) | $26.35B | (m) | $512.00M | (m) | $2.90B | (m) |
| 2018-03-31 | (m) | $1.87B | (m) | $2.79B | (m) | $27.54B | (m) | $519.00M | (m) | $2.98B | (m) |
| 2017-12-31 | (m) | $1.95B | $550.00M | $2.71B | $2.96B | $26.36B | (m) | $513.00M | $37.00M | $2.96B | $0.00 |
| 2017-09-30 | (m) | $1.82B | (m) | $2.71B | (m) | $23.04B | (m) | (m) | (m) | $1.86B | (m) |
| 2017-06-30 | (m) | $1.78B | (m) | $2.60B | (m) | $22.31B | (m) | (m) | (m) | $1.77B | (m) |
| 2017-03-31 | (m) | $1.70B | (m) | $2.42B | (m) | $22.25B | (m) | (m) | (m) | $1.69B | (m) |
| 2016-12-31 | (m) | $1.80B | $566.00M | $2.47B | $1.65B | $22.56B | (m) | $551.00M | $15.00M | $1.65B | $0.00 |
| 2016-09-30 | (m) | $1.62B | (m) | $2.40B | (m) | $22.00B | (m) | (m) | (m) | $1.34B | (m) |
| 2016-06-30 | (m) | $1.65B | (m) | $2.40B | (m) | $21.30B | (m) | (m) | (m) | $1.33B | (m) |
| 2016-03-31 | (m) | $1.58B | (m) | $2.33B | (m) | $21.21B | (m) | (m) | (m) | $1.65B | (m) |
| 2015-12-31 | (m) | $1.69B | $537.00M | $2.40B | $1.58B | $20.97B | (m) | $518.00M | $19.00M | $1.58B | $0.00 |
| 2015-09-30 | (m) | $1.60B | (m) | $2.36B | (m) | $21.03B | (m) | (m) | (m) | $1.57B | (m) |
| 2015-06-30 | (m) | $1.71B | (m) | $2.39B | (m) | $18.26B | (m) | (m) | (m) | $1.05B | (m) |
| 2015-03-31 | (m) | $1.80B | (m) | $2.24B | (m) | $16.69B | (m) | (m) | (m) | $1.39B | (m) |
| 2014-12-31 | (m) | $1.81B | $562.00M | $2.92B | $1.55B | $18.13B | (m) | $541.00M | $21.00M | $1.55B | $0.00 |
| 2014-09-30 | (m) | $1.80B | (m) | $2.68B | (m) | $16.57B | (m) | (m) | (m) | $1.79B | (m) |
| 2014-06-30 | (m) | $1.84B | (m) | $2.41B | (m) | $16.12B | (m) | (m) | (m) | $1.93B | (m) |
| 2014-03-31 | (m) | $1.87B | (m) | $2.44B | (m) | $15.62B | (m) | (m) | (m) | $1.96B | (m) |
| 2013-12-31 | (m) | $1.80B | $540.00M | $2.89B | $1.98B | $15.60B | (m) | $521.00M | $19.00M | $1.98B | $0.00 |
| 2013-09-30 | (m) | $1.72B | (m) | $2.42B | (m) | $15.35B | (m) | (m) | (m) | $1.69B | (m) |
| 2013-06-30 | (m) | $1.92B | (m) | $2.30B | (m) | $15.81B | (m) | (m) | (m) | $1.68B | (m) |
| 2013-03-31 | (m) | $1.82B | (m) | $2.19B | (m) | $15.50B | (m) | (m) | (m) | $1.69B | (m) |
| 2012-12-31 | (m) | $1.76B | $500.00M | $2.28B | $1.63B | $15.84B | (m) | $471.00M | $29.00M | $1.63B | $0.00 |
| 2012-09-30 | (m) | $1.80B | (m) | $2.30B | (m) | $16.34B | (m) | (m) | (m) | $1.78B | (m) |
| 2012-06-30 | (m) | $1.79B | (m) | $2.23B | (m) | $16.47B | (m) | (m) | (m) | $1.75B | (m) |
| 2012-03-31 | (m) | $1.78B | (m) | $2.07B | (m) | $15.40B | (m) | (m) | (m) | $1.79B | (m) |
| 2011-12-31 | (m) | $1.64B | $408.00M | $2.08B | $1.86B | $15.75B | (m) | $389.00M | $19.00M | $1.86B | $0.00 |
| 2011-09-30 | (m) | $1.69B | (m) | $2.20B | (m) | $14.70B | (m) | (m) | (m) | $1.88B | (m) |
| 2011-06-30 | (m) | $1.85B | (m) | $2.29B | (m) | $14.54B | (m) | (m) | (m) | $1.92B | (m) |
| 2011-03-31 | (m) | $1.81B | (m) | $2.08B | (m) | $14.24B | (m) | (m) | (m) | $1.89B | (m) |
| 2010-12-31 | (m) | $1.66B | $387.00M | $2.02B | $1.85B | $14.14B | (m) | $369.00M | $18.00M | $1.85B | $0.00 |
| 2010-09-30 | (m) | $1.65B | (m) | $2.04B | (m) | $14.23B | (m) | (m) | (m) | $1.88B | (m) |
| 2010-06-30 | (m) | $1.76B | (m) | $1.95B | (m) | $14.23B | (m) | (m) | (m) | $1.71B | (m) |
| 2010-03-31 | (m) | $1.58B | (m) | $1.82B | (m) | $14.17B | (m) | (m) | (m) | $1.78B | (m) |
| 2009-12-31 | (m) | $1.45B | (m) | $1.90B | (m) | $13.95B | (m) | (m) | (m) | $1.73B | (m) |
| 2009-09-30 | (m) | $1.40B | (m) | $2.22B | (m) | $14.71B | (m) | (m) | (m) | $1.69B | (m) |
| 2009-06-30 | (m) | $1.24B | (m) | $2.05B | (m) | $14.87B | (m) | (m) | (m) | $1.62B | (m) |
| 2008-12-31 | (m) | $1.30B | (m) | $1.99B | (m) | $15.49B | (m) | (m) | (m) | $1.64B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |